China Universal Asset Management Co., Ltd. Enanta Pharmaceuticals Inc Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 4,494 shares of ENTA stock, worth $22,964. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,494Holding current value
$22,964% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding ENTA
# of Institutions
109Shares Held
21.2MCall Options Held
4.8KPut Options Held
4.6K-
Farallon Capital Management LLC San Francisco, CA2.11MShares$10.8 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$10.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$9.44 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.5MShares$7.66 Million8.7% of portfolio
-
Morgan Stanley New York, NY1.1MShares$5.64 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $106M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...